Mcnulty Korea Co., Ltd
Founded in 1997 and listed on KOSDAQ in 2015, Mcnulty Korea produces coffee under its Mcnulty brand with pharma and health food affiliates.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureMcnulty Korea Co., Ltd was founded in 1997 and listed on KOSDAQ in 2015, operating a vertically integrated coffee business spanning green bean import through roasted coffee production. Under its Mcnulty brand, the company produces roasted coffee, freeze-dried (FD) instant coffee, and ready-to-drink coffee beverages, while affiliates Mcnulty Pharma produces prescription drugs including Ultramag Tab and Mcnulty Bio produces health functional foods including Easy Protein. The coffee business processes purchased green beans through roasting into multiple product lines, the pharmaceutical business supplies products to multiple pharmaceutical companies on a consignment sales basis, and the health functional food business manufactures customized products by client.
Products & technology
- Roasted coffee, etc.Coffee products (Mcnulty brand)
- Ultramag Tab, etc.Prescription pharmaceuticals, etc.
- Easy Protein, etc.Health functional foods, etc.
Clinical trials
data.go.kr8 MFDS clinical trial authorisations · 2012–2016 (Bioequivalence 8)
- Bioequivalence베리맥정 10밀리그램(베포타스틴베실산염)2016-08-18
2 trial sites
- Bioequivalence메피정(메틸프레드니솔론)2015-12-03
2 trial sites
- Bioequivalence글리맥정(콜린알포세레이트)2015-11-19
2 trial sites
- Bioequivalence쎄르펜캡슐(세레콕시브)2015-11-02
2 trial sites
- Bioequivalence하이비스정2015-09-02
2 trial sites
- Bioequivalence오라맥정(에스오메프라졸마그네슘이수화물)2014-11-20
2 trial sites
- Bioequivalence맥널티비티스정(가칭)2012-11-05
1 trial site
- Bioequivalence맥널티비티스정(가칭) 50mg2012-11-05
1 trial site
Companies in the same categoryBiotech & Drug Discovery
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.
KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).
KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.
KONEX-listed biotech venture developing new drug candidates with its multi-target fusion protein platform NTIG®
Biotech company developing fusion-protein immuno-oncology and allergy therapeutics, listed on KOSDAQ since 2023.
SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.
A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.
An ADC (antibody-drug conjugate) developer with its ConjuALL platform, having licensed pipeline assets to Janssen, Ono Pharmaceutical, and other global partners.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition